Arab Finance: The consolidated net profits attributable to the parent company of Minapharm Pharmaceuticals hit EGP 54.851 million in the first nine months of 2025, an annual plunge of 22.76% from EGP 71.018 million, according to the financial results.

Basic and diluted earnings per share (EPS) dropped to EGP 3.42 at the end of September 2025 from EGP 4.88 a year earlier.

Revenues reached EGP 4.840 billion in the first nine months of 2025, up year-on-year (YoY) from EGP 3.580 billion.

Egypt Duty Free Shops’ consolidated profits drop 18.5% YoY in Q1 FY2025/26 Updated 11/30/2025 2:01:00 PM

Cleopatra Hospital’s consolidated profits witness 39.4% YoY leap in 9 months Updated 11/30/2025 1:13:00 PM

Faisal Islamic Bank sees 69.6% YoY lower consolidated profits in 9 months Updated 11/30/2025 9:48:00 AM

Minapharm, Bayer cooperate to localize drug production in Egypt Updated 11/16/2025 9:52:00 AM

Emirates NBD Egypt posts net profit of EGP 4.3B in 9 months Updated 11/4/2025 10:56:00 AM